Commission Actions

FTC, ICPEN, GPEN Announce Results of Review of Use of Dark Patterns Affecting Subscription Services, Privacy

Date

July 10, 2024

The Federal Trade Commission and two international consumer protection networks announced the results of a review of selected websites and apps that showed a large percentage of the websites and...

Report on Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies (2.47 MB)

FTC Submits Comment Supporting Proposed USPTO Terminal Disclaimer Rule

Date

July 10, 2024

The Federal Trade Commission submitted a comment supporting a proposed U.S. Patent and Trademark Office (USPTO) rule regarding new requirements associated with patent terminal disclaimer practice to...

Case Timeline Item

Kroger Company/Albertsons Companies, Inc., In the Matter of (timeline item) - July 10, 2024

Date

July 10, 2024

Notice of Appearance of Non-Party SVF II Strategic Investments AIV LLC - J. Jaeckel (911.3 KB)

Case Timeline Item

Tempur Sealy International, Inc. and Mattress Firm Group Inc., In the Matter of (timeline item) - July 10, 2024

Date

July 10, 2024

Protective Order Governing Confidential Material (696.45 KB)

Order Designating Administrative Law Judge (654.22 KB)

July 9, 2024

Report

Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies

Date

July 9, 2024

Testimony of Chair Lina M. Khan Before the House Committee on Energy and Commerce Subcommittee on Innovation, Data, and Commerce United States House of Representatives (524.67 KB)

Testimony of Chair Lina M. Khan Before the House Committee on Energy and Commerce Subcommittee on Innovation, Data, and Commerce United States House of Representatives

Date

July 9, 2024

Lina M. Khan, Former Chair and Commissioner

Opening Statement of Commissioner Rebecca Kelly Slaughter as prepared for delivery Before the Committee on Energy and Commerce Subcommittee on Innovation, Data & Commerce United States House of Representatives (127.27 KB)

Opening Statement of Commissioner Rebecca Kelly Slaughter as prepared for delivery Before the Committee on Energy and Commerce Subcommittee on Innovation, Data & Commerce

Date

July 9, 2024

Rebecca Kelly Slaughter, Former Commissioner

Statement of Commissioner Alvaro M. Bedoya Before the U.S. House of Representatives Energy & Commerce Committee Subcommittee on Innovation, Data & Commerce for the Hearing: “The Fiscal Year 2025 Federal Trade Commission Budget” (376 KB)

Statement of Commissioner Alvaro M. Bedoya Before the U.S. House of Representatives Energy & Commerce Committee Subcommittee on Innovation, Data & Commerce for the Hearing: “The Fiscal Year 2025 Federal Trade Commission Budget”

Date

July 9, 2024

Alvaro Bedoya, Former Commissioner

Prepared Statement of Commissioner Melissa Holyoak Before the Subcommittee on Innovation, Data, and Commerce of the Energy and Commerce Committee, United States House of Representatives concerning “The Fiscal Year 2025 Federal Trade Commission Budget” (172.17 KB)

Prepared Statement of Commissioner Melissa Holyoak Before the Subcommittee on Innovation, Data, and Commerce of the Energy and Commerce Committee, United States House of Representatives concerning “The Fiscal Year 2025 Federal Trade Commission Budget”

Date

July 9, 2024

Melissa Holyoak, Former Commissioner

Statement of Commissioner Andrew N. Ferguson Before the House Energy and Commerce Committee, Subcommittee on Innovation, Data, and Commerce regarding “The Fiscal Year 2025 Federal Trade Commission Budget” (163.12 KB)

Statement of Commissioner Andrew N. Ferguson Before the House Energy and Commerce Committee, Subcommittee on Innovation, Data, and Commerce regarding “The Fiscal Year 2025 Federal Trade Commission Budget”

Date

July 9, 2024

Andrew N. Ferguson, Chairman

Dissenting Statement of Commissioner Melissa Holyoak In the Matter of the Pharmacy Benefit Managers Report

Date

July 9, 2024

Melissa Holyoak, Former Commissioner

Dissenting Statement of Commissioner Melissa Holyoak In the Matter of the Pharmacy Benefit Managers Report (226.67 KB)

Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report (202.52 KB)

Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report

Date

July 9, 2024

Lina M. Khan, Former Chair and Commissioner;

Alvaro Bedoya, Former Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Concurring Statement of Commissioner Andrew N. Ferguson Regarding the Pharmacy Benefit Managers Interim Staff Report

Date

July 9, 2024

Andrew N. Ferguson, Chairman

Concurring Statement of Commissioner Andrew N. Ferguson Regarding the Pharmacy Benefit Managers Interim Staff Report (231.68 KB)

Concurring Statement of Commissioner Melissa Holyoak In the Matter of NGL Labs, LLC

Date

July 9, 2024

Melissa Holyoak, Former Commissioner

Concurring Statement of Commissioner Melissa Holyoak In the Matter of NGL Labs, LLC (204.22 KB)

Opening Statement of Commissioner Alvaro M. Bedoya Before the U.S. House of Representatives, Energy & Commerce Committee Subcommittee on Innovation, Data, and Commerce "The Fiscal Year 2025 Federal Trade Commission Budget" (255.76 KB)

Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of NGL Labs, LLC, et al.

Date

July 9, 2024

Andrew N. Ferguson, Chairman;

Melissa Holyoak, Former Commissioner

Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of NGL Labs, LLC, et al. (241.96 KB)

Public Statement

Opening Statement of Commissioner Alvaro M. Bedoya Before the U.S. House of Representatives, Energy & Commerce Committee Subcommittee on Innovation, Data, and Commerce "The Fiscal Year 2025 Federal Trade Commission Budget"

Date

July 9, 2024

FTC Releases Interim Staff Report on Prescription Drug Middlemen

Date

July 9, 2024

The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and...